PosterCreation of RUES2 Cell Lines Carrying Targeted Modifications at the HTT Gene26 Feb at 10:29 amRead All
PosterCharacterization of striatal neurons derived from >140 CAG iPSCs for Huntington’s Disease modeling26 Feb at 10:23 amRead All
PosterThe multiplatform utility of human iPSC-derived neuronal models to provide complex biological in vitro systems for drug discovery26 Feb at 7:00 amRead All
PosterEstablishment of a quality-driven manufacturing process to reprogram human donor material into human induced pluripotent stem cells to support drug discovery3 Feb at 9:23 amRead All
PosterDifferentiation of multiple iPSC lines to different cell types to enable cohort analysis in neurodegeneration: challenges and learnings3 Feb at 8:00 amRead All
PosterUtilizing flow cytometry within a quality control process for an iPSC-based manufacturing facilityNovember 27, 2023Read All
PosterValidation of a cortical tri-culture axoModel for in vitro compound screening a blinded compound studyNovember 7, 2023Read All
PosterBuilding a functionally relevant in-vitro model of Alzheimer’s Disease with patient-derived iPSCsJuly 18, 2023Read All
PosterCharacterizations of iPSC derived axoCellsTM cortical inhibitory interneuronsJuly 18, 2023Read All
PosterFunctional and pharmacological differences between the contractility of axoCellsTM iPSC-derived atrial and ventricular cardiomyocytes assessed on the FLEXcyte 96July 10, 2023Read All
PosterPC007 Cross-platform validation of axoCellsTM hiPSC derived cardiomyocytes as a better human model for pre-clinical cardiotoxicity studiesJuly 10, 2023Read All
PosterGeneration and characterization of cryopreserved axoCellsTM human iPSC-derived microgliaJune 19, 2023Read All